Home » Posts tagged with » China
China’s CF PharmTech raises $50m in Series F round for inhalation products

China’s CF PharmTech raises $50m in Series F round for inhalation products

CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing round to accelerate the commercialization of its inhalation products. The investors who took part in the Series F funding round were BioTrack Capital, CICC Qichen, CICC Qide, Watson Investment, SAIC Hengxu, and GP M&A Fund. The existing investors of CF […]

Sinovac Biotech CoronaVac COVID-19 vaccine candidate succeeds in phase 1/2 trial

Sinovac Biotech said that the phase 1/2 clinical trial for its coronavirus vaccine candidate CoronaVac has delivered positive preliminary results by showing favorable immunogenicity and safety profiles. According to the Chinese biopharma company, the phase 1/2 clinical trials are randomized, double-blind and placebo-controlled studies featuring 743 healthy volunteers, aged between 18 and 59 years. Of […]

Continue reading …
COVID-19 RT-PCR detection kit : Fosun Pharma secures FDA EUA status

Shanghai Fosun Pharmaceutical (Fosun Pharma) has been granted the emergency use authorization (EUA) status for its COVID-19 RT-PCR detection kit from the US Food and Drug Administration (FDA). Fosun Long March, a fully-owned subsidiary of Fosun Pharma, developed the COVID-19 RT-PCR detection kit which already has a medical device registration certificate from the China National Medical […]

Continue reading …
SARS-CoV-2 vaccine trial : Sinovac Biotec begins COVID-19 vaccine candidate human trial

SARS-CoV-2 vaccine trial : Chinese biopharma company Sinovac Biotech has started a phase 1 clinical trial for SARS-CoV-2 vaccine, its COVID-19 vaccine candidate in 144 healthy adults, aged between 18 and 59. Sinovac Biotech had recently secured approval from China’s National Medical Products Administration (NMPA) to launch the randomized, double-blinded, placebo-controlled study for the coronavirus […]

Continue reading …
Sinovac Biotech gets approval to begin coronavirus vaccine trial

Coronavirus vaccine trial : Chinese biopharma company Sinovac Biotech has secured approval to carry out a human clinical trial on an inactivated COVID-19 vaccine candidate, which it had been developing since late January. The company said that its scientists have quickly wrapped up comprehensive preclinical studies in collaboration with some of the top academic research […]

Continue reading …
Seneca Biopharma completes cell manufacturing facility in Suzhou, China

Seneca Biopharma (formerly Neuralstem), a biopharma company engaged in developing treatments for diseases of high unmet medical need, has completed construction on its new cell manufacturing facility in Suzhou, China. The cell manufacturing facility will be used  for manufacture NSI-566, the lead stem cell therapy of Seneca Biopharma for clinical trials in China, which includes […]

Continue reading …
COVID-19 treatment : Cyclica, Institute of Materia Medica partner on drug repurposing for coronavirus

COVID-19 treatment : The Institute of Materia Medica, Chinese Academy of Medical Sciences has entered into a collaboration with Canadian biotech company Cyclica for discovering antiviral drug candidates for COVID-19 (novel coronavirus) and for exploring opportunities for designing multi-targeted antiviral compounds. According to the partners, new drug development efforts to tackle the prevailing pandemic of […]

Continue reading …
ImmunoPrecise Antibodies launches vaccine development program for COVID-19

ImmunoPrecise Antibodies has launched a coronavirus vaccine development program to address the new coronavirus originating in Wuhan, China apart from developing coronavirus-neutralizing antibodies for addressing prophylactic and therapeutic measures to counter the virus and its associated disease, COVID-19. So far, COVID-19 has claimed the lives of nearly 1,875 people, while infecting more than 74,000 across […]

Continue reading …
Wuhan coronavirus : AirPHX non-thermal plasma technology to protect from deadly virus

AirPHX said that an independent testing lab has confirmed that its non-thermal plasma technology is highly effective in protecting people from potential exposure to the Wuhan coronavirus or novel coronavirus (2019-nCoV). The technology from airPHX can be scaled for the treatment of air and surfaces in large facilities like hospitals, hotels, airports, schools, and other […]

Continue reading …
Traveler brings Novel Coronavirus in US from Chinese city Wuhan

Wuhan Coronavirus cases in US : The deadly Novel Coronavirus (2019-nCoV infection) has made its way to the US owing to the return of a traveler from China, as confirmed by the Centers for Disease Control and Prevention (CDC). The first Novel Coronavirus case in US has been reported from Washington State after a patient […]

Continue reading …
Page 1 of 3123